Počet záznamov: 1
trastuzumab emtanzín
SYS d000080044 LBL 00000cx^^^2200181-^^45^^ 005 20240119195338.3 100 $a 20200101asloy0103 ba0 152 $b mesh 250 $a trastuzumab emtanzín $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2020 (2010) $8 eng 330 1-
$a Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination. $8 eng 450 $a Trastuzumab Emtansine $5 e $8 eng 450 $a Trastuzumab-DM1 $5 e $8 eng 450 $a Trastuzumab-DM1 Conjugate $5 e $8 eng 450 $a Kadcyla $5 e $8 slo 450 $a ado-trastuzumab emtanzín $5 e $8 slo 450 $a trastuzumab-DM1 konjugát $5 e $8 slo 686 $a D02.540.505.495.500 686 $a D04.345.295.500.500 686 $a D12.776.124.486.485.114.224.060.875.500 686 $a D12.776.124.790.651.114.224.060.875.500 686 $a D12.776.377.715.548.114.224.200.875.500 750 $a Ado-Trastuzumab Emtansine $8 eng 801 -0
$a SK $b BA006 $c 20200216 801 -2
$a SK $b BA006 $c 20200217 801 -2
$a SK $b BA006 $c 20200903 980 $x M
Počet záznamov: 1